1887
Research Open Access
Like 0

Abstract

BACKGROUND

Dual penicillin- and ciprofloxacin-resistant causing invasive meningococcal disease (IMD) have recently emerged in association with sequence type (ST) 3587, harbouring ROB-1 β-lactamase ( ) and a mutated DNA gyrase (). These strains pose a threat to current antimicrobial treatment and prophylaxis.

AIM

We aimed to characterise the first dual-resistant ST-3587 isolates harbouring and a mutated identified in Spain.

METHODS

Three isolates encoding were identified in 2024. They were characterised by whole genome sequencing to determine capsular genogroups, ST and genetic antimicrobial resistance markers. Dated phylogenetic analysis was performed alongside global ST-3587 strains.

RESULTS

The three -encoding isolates belonged to ST-3587, genogroup Y, harboured a T91I mutation in and showed resistance to penicillin and ciprofloxacin. These isolates were obtained from urethral, oropharyngeal and blood samples, each from a different patient. According to the dated phylogenetic analysis of ST-3587 and the presence of , two clades were defined: clade I and clade II. Within clade II, subclade II.I was identified, comprising isolates which, in addition to , carried the T91I mutation in . This subclade included the three Spanish isolates, which exhibited close genetic relatedness.

CONCLUSION

This study documents the emergence of ST-3587 with dual resistance in Europe, including a documented urogenital infection by this lineage. Continued surveillance of antimicrobial resistance in , including non-invasive cases, is crucial for timely public health responses and effective IMD prevention strategies.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2026.31.4.2500398
2026-01-29
2026-02-08
/content/10.2807/1560-7917.ES.2026.31.4.2500398
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/31/4/eurosurv-31-4-3.html?itemId=/content/10.2807/1560-7917.ES.2026.31.4.2500398&mimeType=html&fmt=ahah

References

  1. Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3-9.  https://doi.org/10.1016/j.vaccine.2011.12.062  PMID: 22607896 
  2. Pérez-García JA, Vera-García M, Arriaza-Rubio R, Del Romero-Guerrero J. Atypical urethritis and proctitis in a heterosexual couple. Enferm Infecc Microbiol Clin (Engl Ed). 2023;41(5):305-6.  https://doi.org/10.1016/j.eimce.2022.12.001  PMID: 36588029 
  3. Ladhani SN, Lucidarme J, Parikh SR, Campbell H, Borrow R, Ramsay ME. Meningococcal disease and sexual transmission: urogenital and anorectal infections and invasive disease due to Neisseria meningitidis. Lancet. 2020;395(10240):1865-77.  https://doi.org/10.1016/S0140-6736(20)30913-2  PMID: 32534649 
  4. Rodriguez E, Tzeng YL, Berry I, Howie R, McNamara L, Stephens DS. Progression of antibiotic resistance in Neisseria meningitidis. Clin Microbiol Rev. 2025;38(1):e0021524.  https://doi.org/10.1128/cmr.00215-24  PMID: 39887238 
  5. Zapun A, Morlot C, Taha MK. Resistance to β-lactams in Neisseria ssp due to chromosomally encoded penicillin-binding proteins. Antibiotics (Basel). 2016;5(4):35.  https://doi.org/10.3390/antibiotics5040035  PMID: 27690121 
  6. Chen M, Shao Y, Luo J, Yuan L, Wang M, Chen M, et al. Penicillin and cefotaxime resistance of quinolone-resistant Neisseria meningitidis clonal complex 4821, Shanghai, China, 1965-2020. Emerg Infect Dis. 2023;29(2):341-50.  https://doi.org/10.3201/eid2902.221066  PMID: 36692352 
  7. Chen M, Guo Q, Wang Y, Zou Y, Wang G, Zhang X, et al. Shifts in the antibiotic susceptibility, serogroups, and clonal complexes of Neisseria meningitidis in Shanghai, China: a time trend analysis of the pre-quinolone and quinolone eras. PLoS Med. 2015;12(6):e1001838, discussion e1001838.  https://doi.org/10.1371/journal.pmed.1001838  PMID: 26057853 
  8. Potts CC, Retchless AC, McNamara LA, Marasini D, Reese N, Swint S, et al. Acquisition of ciprofloxacin resistance among an expanding clade of β-lactamase-positive, serogroup Y Neisseria meningitidis in the United States. Clin Infect Dis. 2021;73(7):1185-93.  https://doi.org/10.1093/cid/ciab358  PMID: 33900407 
  9. Marín JEO, Villatoro E, Luna MJ, Barrientos AM, Mendoza E, Lemos APS, et al. Emergence of MDR invasive Neisseria meningitidis in El Salvador, 2017-19. J Antimicrob Chemother. 2021;76(5):1155-9.  https://doi.org/10.1093/jac/dkab010  PMID: 33517418 
  10. Hong E, Deghmane AE, Taha MK. Acquisition of beta-lactamase by Neisseria meningitidis through possible horizontal gene transfer. Antimicrob Agents Chemother. 2018;62(9):e00831-18.  https://doi.org/10.1128/AAC.00831-18  PMID: 29941641 
  11. Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health. 2023;5(9):e582-93.  https://doi.org/10.1016/S2589-7500(23)00108-5  PMID: 37516557 
  12. Roca-Grande J, Mir-Cros A, Muñoz-Almagro C, Lung M, Bellés-Bellés A, Càmara J, et al. Genomic characterization of invasive Neisseria meningitidis in Spain (2011/12-2022/23): expansion of clonal complex 213 and the potential threat to 4CMenB vaccine strain coverage. Emerg Microbes Infect. 2025;14(1):2482696.  https://doi.org/10.1080/22221751.2025.2482696  PMID: 40105365 
  13. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.  https://doi.org/10.12688/wellcomeopenres.14826.1  PMID: 30345391 
  14. Croucher NJ, Page AJ, Connor TR, Delaney AJ, Keane JA, Bentley SD, et al. Rapid phylogenetic analysis of large samples of recombinant bacterial whole genome sequences using Gubbins. Nucleic Acids Res. 2015;43(3):e15.  https://doi.org/10.1093/nar/gku1196  PMID: 25414349 
  15. Didelot X, Croucher NJ, Bentley SD, Harris SR, Wilson DJ. Bayesian inference of ancestral dates on bacterial phylogenetic trees. Nucleic Acids Res. 2018;46(22):e134.  https://doi.org/10.1093/nar/gky783  PMID: 30184106 
  16. McNamara LA, Potts C, Blain AE, Retchless AC, Reese N, Swint S, et al. Detection of ciprofloxacin-resistant, β-lactamase-producing Neisseria meningitidis serogroup Y isolates - United States, 2019-2020. MMWR Morb Mortal Wkly Rep. 2020;69(24):735-9.  https://doi.org/10.15585/mmwr.mm6924a2  PMID: 32555137 
  17. Takahashi H, Ohama Y, Horiba K, Fukusumi M, Sunagawa T, Ariyoshi T, et al. Emergence of high-level penicillin-resistant Neisseria meningitidis harboring ROB-1-type β-lactamase gene in Japan. J Infect Chemother. 2025;31(4):102679.  https://doi.org/10.1016/j.jiac.2025.102679  PMID: 40081739 
  18. Tsang RSW, Ahmad T, Jamieson FB, Tyrrell GJ. WGS analysis of a penicillin-resistant Neisseria meningitidis strain containing a chromosomal ROB-1 β-lactamase gene. J Antimicrob Chemother. 2019;74(1):22-8. PMID: 30295754 
  19. Retchless AC, Kretz CB, Chang HY, Bazan JA, Abrams AJ, Norris Turner A, et al. Expansion of a urethritis-associated Neisseria meningitidis clade in the United States with concurrent acquisition of N. gonorrhoeae alleles. BMC Genomics. 2018;19(1):176.  https://doi.org/10.1186/s12864-018-4560-x  PMID: 29499642 
  20. Bazan JA, Turner AN, Kirkcaldy RD, Retchless AC, Kretz CB, Briere E, et al. Large cluster of Neisseria meningitidis urethritis in Columbus, Ohio, 2015. Clin Infect Dis. 2017;65(1):92-9.  https://doi.org/10.1093/cid/cix215  PMID: 28481980 
  21. van Hal SJ, Le T, Jenkins F, Kundu RL, Limnios EA, McNamara LA, et al. Neisseria meningitidis serogroup Y sequence type 1466 and urogenital infections. Emerg Infect Dis. 2025;31(1):86-93.  https://doi.org/10.3201/eid3101.240940  PMID: 39714304 
  22. Tsakalos A, Xirogianni A, Ekonomou G, Papandreou A, Prokopiou E, Vagiakou E, et al. Symptomatic female genital tract infections due to Neisseria meningitidis in Athens, Greece. Diagnostics (Basel). 2021;11(7):1265.  https://doi.org/10.3390/diagnostics11071265  PMID: 34359348 
  23. Khoder M, Osman M, Kassem II, Rafei R, Shahin A, Diene SM, et al. Genomic analysis of Neisseria meningitidis ST23 serogroup Y isolated from the semen. New Microbes New Infect. 2023;53:101129.  https://doi.org/10.1016/j.nmni.2023.101129  PMID: 37216023 
  24. Ministerio de Sanidad, Consumo y Bienestar Social. Recomendaciones de vacunación frente a la enfermedad meningocócica invasiva. [Vaccination recommendations against invasive meningococcal disease]. Madrid: Ministerio de Sanidad, Consumo y Bienestar Social; Mar 2019. Spanish. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/docs/Recomendaciones_Vacunacion_Meningococo.pdf
  25. Departament de Salud de la Generalitat de Catalunya (Canal Salut). Vacunació d’adolescents i joves contra el meningococ ACWY. [Vaccination of adolescents and young people against meningococcus ACWY]. Barcelona: Canal Salut; 28 Aug 2025. Catalan. Available from: http://canalsalut.gencat.cat/ca/salut-a-z/v/vacunacions/infantil/meningococ-acwy/index.html
  26. McNamara LA, Topaz N, Wang X, Hariri S, Fox L, MacNeil JR. High risk for invasive meningococcal disease among patients receiving Eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66(27):734-7.  https://doi.org/10.15585/mmwr.mm6627e1  PMID: 28704351 
  27. Pizza M, Bekkat-Berkani R, Rappuoli R. Vaccines against meningococcal diseases. Microorganisms. 2020;8(10):1521.  https://doi.org/10.3390/microorganisms8101521  PMID: 33022961 
/content/10.2807/1560-7917.ES.2026.31.4.2500398
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error